Literature DB >> 34344437

Epidemiological investigation of hemophagocytic lymphohistiocytosis in China.

Shuyan Yao1, Yini Wang2, Yuan Sun3, Li Liu4, Rui Zhang5, Jianpei Fang6, Runming Jin7, Jie Yu8, Fei Li9, Jie Bai10, Yun Zeng11, Cheng Zhang12, Huo Tan13, Fan Zhou14, Yan Chen15, Qiaohua Zhang16, Zhao Wang17.   

Abstract

BACKGROUND: Currently, most research on hemophagocytic lymphohistiocytosis (HLH) have focused on etiology and therapy, leaving few epidemiological reports. The published studies of China are mainly regional investigations. We aimed to present the overall epidemiological status of HLH in China, and provide Chinese data for the international HLH epidemiological investigation.
METHODS: The data of HLH cases in China in 2019 were collected and statistically analyzed.
FINDINGS: Epstein-Barr virus accounted for 44.01% of the 1445 cases in 31 regions and was the most common cause. Lymphoma-associated HLH patients were more often male (P < 0.05) while rheumatic and immune-associated HLH were more often female (P < 0.001). Primary HLH and Epstein-Barr Virus-associated HLH were predominant in children (P < 0.001) while tumor-associated HLH was predominant in adults. Lymphoma-associated HLH was positively correlated with the age of onset (P < 0.01). The diagnosis rate of 29 areas had a significant correlation with per capita Gross domestic product (P < 0.05).
CONCLUSION: The different distribution of HLH etiology by age and gender contributes to the diagnosis of HLH by clinicians; The suboptimal diagnosis rate in regions with a high incidence of HLH in China is a result of the effect of the local economic level indicating the importance of improving the regional medical level.
© 2021. The Author(s).

Entities:  

Keywords:  Diagnosis rate; Epidemiology; Gross domestic product; Hemophagocytic lymphohistiocytosis; Incidence

Year:  2021        PMID: 34344437     DOI: 10.1186/s13023-021-01976-1

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  22 in total

1.  Adult onset of primary hemophagocytic syndrome in subjects carrying PRF1 mutations.

Authors:  Yini Wang; Zhao Wang; Hua Chen; Xiaolin Wang
Journal:  Ann Hematol       Date:  2012-01-17       Impact factor: 3.673

2.  Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients.

Authors:  Yanchun Zhao; Danlei Lu; Shanshan Ma; Li Li; Jingjing Zhu; Yanlong Zheng; Xiudi Yang; Lixia Zhu; Mingyu Zhu; Mixue Xie; Jianai Sun; Xiujin Ye; Wanzhuo Xie
Journal:  Hematology       Date:  2019-12       Impact factor: 2.269

3.  Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.

Authors:  Xiaoyan Shao; Ye Xu; Xihui Xu; Yong Xu; Hu Chen; Ming Hong; Lingxiang Liu
Journal:  Isr Med Assoc J       Date:  2018-02       Impact factor: 0.892

Review 4.  Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review.

Authors:  Anna Hayden; Sujin Park; Dean Giustini; Agnes Y Y Lee; Luke Y C Chen
Journal:  Blood Rev       Date:  2016-05-20       Impact factor: 8.250

5.  Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

Authors:  Rachel J Bubik; Dylan M Barth; Christopher Hook; Robert C Wolf; Jessica M Muth; Kristin Mara; Mrinal S Patnaik; Rajiv K Pruthi; Ariela L Marshall; Mark R Litzow; Michelle A Elliott; William J Hogan; Mithun V Shah; Kebede H Begna; Hassan Alkhateeb; Animesh Pardanani; Aneel A Ashrani; Timothy G Call; Candido E Rivera; John K Camoriano; Ronald S Go; Alexandra P Wolanskyj-Spinner; Sameer A Parikh
Journal:  Leuk Lymphoma       Date:  2020-03-11

Review 6.  Hemophagocytic Lymphohistiocytosis in Children: Pathogenesis and Treatment.

Authors:  Eiichi Ishii
Journal:  Front Pediatr       Date:  2016-05-13       Impact factor: 3.418

7.  Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Authors:  Reiji Muto; Hiroaki Miyoshi; Kensaku Sato; Takuya Furuta; Hiroko Muta; Keisuke Kawamoto; Eriko Yanagida; Kyohei Yamada; Koichi Ohshima
Journal:  Cancer Med       Date:  2018-10-11       Impact factor: 4.452

8.  Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy.

Authors:  Jae-Ho Yoon; Sung-Soo Park; Young-Woo Jeon; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Jong Wook Lee
Journal:  Haematologica       Date:  2018-09-13       Impact factor: 9.941

Review 9.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

10.  Clinical profiles and risk factors of 7-day and 30-day mortality among 160 pediatric patients with hemophagocytic lymphohistiocytosis.

Authors:  Xun Li; Haipeng Yan; Xinping Zhang; Jiaotian Huang; Shi-Ting Xiang; Zhenya Yao; Ping Zang; Desheng Zhu; Zhenghui Xiao; Xiulan Lu
Journal:  Orphanet J Rare Dis       Date:  2020-08-31       Impact factor: 4.123

View more
  3 in total

1.  Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.

Authors:  Shuyan Yao; Zhili Jin; Lingbo He; Ruoxi Zhang; Menghan Liu; Zhengjie Hua; Zhao Wang; Yini Wang
Journal:  Front Oncol       Date:  2021-12-06       Impact factor: 6.244

2.  Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.

Authors:  Ailin Zhao; Jinrong Yang; Meng Li; Linfeng Li; Xinai Gan; Jie Wang; He Li; Kai Shen; Yunfan Yang; Ting Niu
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Spectrum and trigger identification of hemophagocytic lymphohistiocytosis in adults: A single-center analysis of 555 cases.

Authors:  Yi Miao; Jing Zhang; Qingqing Chen; Lingxiao Xing; Tonglu Qiu; Huayuan Zhu; Li Wang; Lei Fan; Wei Xu; Jianyong Li
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.